Power Law company profile

AbCellera Biologics

Biotech & Life Sciences · Vancouver, Canada · Founded 2012 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$767M

Market cap · Apr/2026

Revenue

$75M

Latest reported FY

Investors

8 investors on AbCellera Biologics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

DCVC

Series B+ 7 investors entered at this stage

Viking Global Investors

Northview LifeSciences

OrbiMed

Peter Thiel

Eli Lilly

The University of British Columbia

Presight Capital

Global footprint

Where AbCellera Biologics has talent and traffic

AI talent share

3.8% of workforce is AI talent
(22 of 576 staff)

Core AI81.39%

Other AI142.43%

Non-AI workforce55496.18%

Web traffic by country

30K monthly visits
across markets

🇨🇦 Canada46.7%

🇺🇸 United States18.3%

🏳️ Korea10%

🏳️ Republic of7.3%

🇮🇳 India5.7%

Top 5 markets shown

Patent intelligence

$63M patent portfolio · 45 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$63M

8.2% of market cap · 3.5× smaller than top peer Ganymed Pharmaceuticals ($223M)

45 active patent families

Where AbCellera Biologics innovates DiseaseMolecular biologyAntiendomysial antibodiesImmunologyBioinformatics

Above peer median on Strategic · Below peer median on Legal, Market

Quality vs same-sector peers

AbCellera Biologics on the five Patsnap quality dimensions

AbCellera Biologics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where AbCellera Biologics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across AbCellera Biologics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See AbCellera Biologics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo